Zimmer Biomet Holdings (ZBH) Stock Buyback History
TTM buyback yield 4.22% · Shareholder yield (TTM) 4.22%.
TTM buyback yield
4.22%
Shareholder yield (TTM)
4.22%
5Y share count change
-4.0%
TTM buyback spend
$744.30M
SBC coverage (TTM)
7.85x
YoY change in spend
-43.9%
5Y CAGR of spend
N/A
Peak year (2011)
$1.05B
Cumulative spend
$8.94B
TTM metrics calculated from the four most recent reported quarters, ending (reported ).
Key takeaways
- Zimmer Biomet Holdings (ZBH) repurchased about $744.30M of stock over the trailing twelve months.
- Diluted share count is down 4.0% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- TTM buyback ÷ stock-based-comp ratio of 7.85× — repurchases more than cover SBC dilution.
- TTM repurchases used about 45% of free cash flow remaining after dividends.
Buyback context per fiscal year
Annual repurchases alongside stock-based compensation, diluted share count and the year-over-year change — useful for SBC-coverage and dilution-offset reading at a glance.
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $487.00M | $0.00 | $487.00M | 0.20B | -2.6% | 2.75% |
| 2024 | $868.00M | $101.00M | $767.00M | 0.20B | -2.8% | 4.13% |
| 2023 | $692.20M | $99.80M | $592.40M | 0.21B | -0.3% | 2.74% |
| 2022 | $126.40M | $105.00M | $21.40M | 0.21B | -0.0% | 0.47% |
| 2021 | $0.00 | $76.00M | −$76.00M | 0.21B | 1.6% | — |
| 2020 | $0.00 | $73.80M | −$73.80M | 0.21B | 0.1% | — |
| 2019 | $0.00 | $84.30M | −$84.30M | 0.21B | 1.6% | — |
| 2018 | $0.00 | $65.50M | −$65.50M | 0.20B | -0.1% | — |
| 2017 | $0.00 | $53.70M | −$53.70M | 0.20B | 0.6% | — |
| 2016 | $415.50M | $57.30M | $358.20M | 0.20B | 6.6% | 2.07% |
| 2015 | $150.00M | $46.40M | $103.60M | 0.19B | 10.5% | 0.75% |
| 2014 | $400.90M | $49.40M | $351.50M | 0.17B | -0.1% | 2.14% |
| 2013 | $720.80M | $48.50M | $672.30M | 0.17B | -2.4% | 4.67% |
| 2012 | $485.60M | $55.00M | $430.60M | 0.18B | -6.7% | 4.45% |
| 2011 | $1.05B | $60.50M | $989.50M | 0.19B | -6.2% | 11.42% |
| 2010 | $505.60M | $62.00M | $443.60M | 0.20B | -6.8% | 5.04% |
| 2009 | $923.70M | $75.30M | $848.40M | 0.22B | -5.5% | 7.94% |
| 2008 | $737.00M | $69.90M | $667.10M | 0.23B | -3.9% | 8.49% |
| 2007 | $576.30M | $0.00 | $576.30M | 0.24B | -3.2% | 3.86% |
| 2006 | $798.80M | $0.00 | $798.80M | 0.25B | -1.8% | 4.43% |
| 2005 | $4.10M | $0.00 | $4.10M | 0.25B | 0.8% | 0.03% |
| 2004 | $0.00 | $0.00 | $0.00 | 0.25B | 17.3% | — |
| 2003 | $0.00 | $0.00 | $0.00 | 0.21B | 7.3% | — |
| 2002 | $0.00 | $0.00 | $0.00 | 0.20B | 1.3% | — |
| 2001 | $0.00 | $0.00 | $0.00 | 0.19B | 0.4% | — |
| 2000 | $0.00 | $0.00 | $0.00 | 0.19B | 0.0% | — |
| 1999 | $0.00 | $0.00 | $0.00 | 0.19B | -0.1% | — |
| 1998 | $0.00 | $0.00 | $0.00 | 0.19B | — | — |
Cash buyback spend (USD) — annual & quarterly history
Trailing-twelve-month and per-period cash repurchases for Zimmer Biomet Holdings (ZBH) from the consolidated cash flow statement (line: common stock repurchased), in USD as filed.
Cash buyback spend over time for Zimmer Biomet Holdings (ZBH)
Per-period cash repurchases
Cash buyback spend annual + quarterly history for Zimmer Biomet Holdings (ZBH)
| Fiscal year | Period ended | Reported | Buyback Spend | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $487.00M | -43.9% | -$381.00M | ||
| 2024 | $868.00M | +25.4% | +$175.80M | ||
| 2023 | $692.20M | +447.6% | +$565.80M | ||
| 2022 | $126.40M | — | +$126.40M | ||
| 2021 | $0 | — | $0 | ||
| 2020 | $0 | — | $0 | ||
| 2019 | $0 | — | $0 | ||
| 2018 | $0 | — | $0 | ||
| 2017 | $0 | -100.0% | -$415.50M | ||
| 2016 | $415.50M | +177.0% | +$265.50M | ||
| 2015 | $150.00M | -62.6% | -$250.90M | ||
| 2014 | $400.90M | -44.4% | -$319.90M | ||
| 2013 | $720.80M | +48.4% | +$235.20M | ||
| 2012 | $485.60M | -53.8% | -$564.40M | ||
| 2011 | $1.05B | +107.7% | +$544.40M | ||
| 2010 | $505.60M | -45.3% | -$418.10M | ||
| 2009 | $923.70M | +25.3% | +$186.70M | ||
| 2008 | $737.00M | +27.9% | +$160.70M | ||
| 2007 | $576.30M | -27.9% | -$222.50M | ||
| 2006 | $798.80M | +19382.9% | +$794.70M | ||
| 2005 | $4.10M | — | +$4.10M | ||
| 2004 | $0 | — | $0 | ||
| 2003 | $0 | — | $0 | ||
| 2002 | $0 | — | $0 | ||
| 2001 | $0 | — | $0 | ||
| 2000 | $0 | — | $0 | ||
| 1999 | $0 | — | $0 | ||
| 1998 | $0 | — | — |
2025's annual buyback spend for Zimmer Biomet Holdings (ZBH) came in at $487.00M – plunged 43.9% year-over-year.
Over 2015–2025 (10 years), Zimmer Biomet Holdings buyback spend expanded at a +12.5% compound annual rate, with the latest reading among the more recent periods of the dataset.
Zimmer Biomet Holdings buyback spend plunged from $1.05B in 2011 to $487.00M in 2025, a 53.6% drawdown.
$1.05B stands as the all-time-high annual buyback spend, posted in 2011, against a low of $0 during 1998.
Zimmer Biomet Holdings (ZBH) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $2.75B.
Zimmer Biomet Holdings Buyback Spend 2025: $487.00M
Zimmer Biomet Holdings buyback spend in 2025 was $487.00M, plunged 43.9% below 2024.
Zimmer Biomet Holdings Buyback Spend 2024: $868.00M
Zimmer Biomet Holdings buyback spend in 2024 was $868.00M, grew 25.4% from 2023.
Zimmer Biomet Holdings Buyback Spend 2023: $692.20M
Zimmer Biomet Holdings buyback spend in 2023 was $692.20M, surged 447.6% from 2022.
Zimmer Biomet Holdings Buyback Spend 2022: $126.40M
Zimmer Biomet Holdings buyback spend in 2022 was $126.40M.
Zimmer Biomet Holdings Buyback Spend 2021: $0
Zimmer Biomet Holdings buyback spend in 2021 was $0.
See more financial history for Zimmer Biomet Holdings (ZBH).
Sector peers by buyback spend
Companies in the same sector as Zimmer Biomet Holdings, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group (UNH) | $5.54B | Healthcare |
| Merck & Co. (MRK) | $5.08B | Healthcare |
| Eli Lilly (LLY) | $4.11B | Healthcare |
| Novo Nordisk (NVO) | $1.39B | Healthcare |
| AbbVie (ABBV) | $980.00M | Healthcare |
| AstraZeneca (AZN) | $719.66M | Healthcare |
| Amgen (AMGN) | $0 | Healthcare |
Share count history
Diluted weighted-average shares drive the EPS denominator and per-share capital-return maths. A falling diluted share count means buybacks are outpacing dilution from stock-based compensation and option exercises.
Diluted vs basic shares (annual)
Year-over-year change in diluted shares
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield over time
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Buybacks vs stock-based compensation
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 7.85×.
Capital allocation mix
How Zimmer Biomet Holdings splits cash returned to shareholders between dividends and buybacks, plus the headroom on free cash flow that's still available for additional repurchases.
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $1.65B (TTM FCF − TTM dividends, clamped at zero).
Data & methodology
Where do buyback, dividend and compensation figures come from?
Cash buyback spend (common stock repurchased), dividends paid and stock-based compensation come from Zimmer Biomet Holdings's consolidated cash flow statements — quarterly 10-Q and annual 10-K SEC filings, in USD as reported.
How are diluted shares and yields calculated?
Diluted weighted-average share counts come from the income statement (EPS denominator). Trailing twelve-month (TTM) aggregates sum the four most recent reported quarters. Buyback and dividend yields divide TTM cash flows by market capitalisation at the latest quarter-end.
How is buyback capacity defined?
Capacity compares TTM repurchases to free cash flow after dividends: operating cash flow minus capital expenditure, minus dividends paid, versus actual buybacks over the same trailing window.
Is this investment advice?
No. Figures are for informational and educational use only. Past buybacks and dividends do not predict future returns.
Frequently asked questions
Does Zimmer Biomet Holdings buy back its own stock?
Yes, Zimmer Biomet Holdings (ZBH) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
How much does Zimmer Biomet Holdings spend on share buybacks?
Trailing twelve months (TTM) buyback spend is about $744.30M (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.
What is Zimmer Biomet Holdings's buyback yield?
TTM buyback yield is about 4.22% (TTM buyback spend divided by market cap at the latest quarter-end in our data).
What is Zimmer Biomet Holdings's shareholder yield?
Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 4.22% combined (TTM-based where available).
Is Zimmer Biomet Holdings diluting shareholders?
Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Zimmer Biomet Holdings's share count changed?
Diluted weighted average shares changed by about -4.0% over roughly five fiscal years (annual income statement data).
What is Zimmer Biomet Holdings's buyback spend?
Latest reported buyback spend for Zimmer Biomet Holdings (ZBH) is $744.30M (period ending March 31, 2026).
How has Zimmer Biomet Holdings buyback spend changed year-over-year?
Zimmer Biomet Holdings (ZBH) buyback spend changed -43.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Zimmer Biomet Holdings buyback spend?
Zimmer Biomet Holdings (ZBH) buyback spend compound annual growth rate is +12.5% over the most recent 10 years available.
When did Zimmer Biomet Holdings buyback spend hit its highest annual value?
Zimmer Biomet Holdings buyback spend reached its highest annual value of $1.05B in 2011.
What was Zimmer Biomet Holdings buyback spend in 2024?
Zimmer Biomet Holdings (ZBH) buyback spend in 2024 was $868.00M.
What was Zimmer Biomet Holdings buyback spend in 2025?
Zimmer Biomet Holdings (ZBH) buyback spend in 2025 was $487.00M.
Explore more
ZBH Overview
Company profile, financial tools, and key metrics
ZBH Revenue Counter
Earns $266.65 every second. See per minute, hour, and day.
ZBH Earnings Counter
Earns $24.14 per second net profit. See per minute, hour, and day.
ZBH Economic Scale
Exceeds Montenegro's GDP. Compare with world economies.
ZBH What If Invested
What if you had invested $1,000? See historical returns from any date.
ZBH How It Makes Money
Discover visual breakdown of $8.41B in revenue — where it comes from and where it goes.
ZBH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ZBH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ZBH Daily Price Character
Steady · 50.9% historical win rate (green days). Streaks & record days.
ZBH Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
ZBH Dividend Profile
Yield: 1.12%. Safety: 6/8. See full history.
ZBH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ZBH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.
ZBH Dividend Capture
Historical pre-ex touch stats, gap distribution, after-tax calculator, and a backtest simulator (limit-order vs MOC exit).
ZBH Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.